CRANIAL SUTURES WIDENING

This adverse event was reported 138 times

These drugs are most commonly taken by patients reporting CRANIAL SUTURES WIDENING:

# Drug Count
0 VALSARTAN 42
1 VALSARTAN ORAL 41
2 CANDESARTAN 15
3 RAMIPRIL 13
4 OLMESARTAN MEDOXOMIL 11
5 METOPROLOL 8
6 METOPROLOL TARTRATE 8
7 METOPROLOL TARTRATE INJECTION 8
8 AMLODIPINE 7
9 FOLIC ACID 7
See all common drugs associated with CRANIAL SUTURES WIDENING

CRANIAL SUTURES WIDENING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHYLDOPA 6 0.0012
1 TERBUTALINE SULFATE 2 0.0011
2 SULINDAC 2 0.0008
3 BECLOMETHASONE DIPROPIONATE 4 0.0007
4 NELFINAVIR MESYLATE 1 0.0005
5 CANDESARTAN 15 0.0004
6 OLMESARTAN MEDOXOMIL 11 0.0003
7 CANDESARTAN CILEXETIL 6 0.0002
8 MAGNESIUM SULFATE HEPTAHYDRATE 2 0.0002
9 INDOMETHACIN 2 0.0002
See all drugs enriched for association with CRANIAL SUTURES WIDENING

CRANIAL SUTURES WIDENING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Angiotensin 2 Receptor Blocker [EPC] 44 0.0001
1 Vitamin K [EPC] 1 0.0001
2 Angiotensin Converting Enzyme Inhibitor [EPC] 13 0.0001
3 Nitrofuran Antibacterial [EPC] 1 0.0001
4 Purine Antimetabolite [EPC] 5 0.0001
5 Dihydropyridine Calcium Channel Blocker [EPC] 11 0.0000
6 Thiazide Diuretic [EPC] 5 0.0000
7 Vitamin D [EPC] 7 0.0000
8 Protease Inhibitor [EPC] 1 0.0000
9 Vitamin B12 [EPC] 7 0.0000
See all drug classes enriched for association with CRANIAL SUTURES WIDENING